Correlation Between Shandong Ruifeng and Innovative Medical

Can any of the company-specific risk be diversified away by investing in both Shandong Ruifeng and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shandong Ruifeng and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shandong Ruifeng Chemical and Innovative Medical Management, you can compare the effects of market volatilities on Shandong Ruifeng and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shandong Ruifeng with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shandong Ruifeng and Innovative Medical.

Diversification Opportunities for Shandong Ruifeng and Innovative Medical

0.51

Correlation Coefficient

Shandong Ruifeng  Innovative Medical

Very weak diversification

The 3 months correlation between Shandong and Innovative is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Shandong Ruifeng Chemical and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Shandong Ruifeng is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shandong Ruifeng Chemical are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Shandong Ruifeng i.e., Shandong Ruifeng and Innovative Medical go up and down completely randomly.

Pair Corralation between Shandong Ruifeng and Innovative Medical

Assuming the 90 days trading horizon Shandong Ruifeng Chemical is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Shandong Ruifeng Chemical is 1.44 times less risky than Innovative Medical. The stock trades about -0.26 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  955.00  in Innovative Medical Management on October 7, 2024 and sell it today you would lose (144.00) from holding Innovative Medical Management or give up 15.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Shandong Ruifeng Chemical  vs.  Innovative Medical Management

Shandong Ruifeng Chemical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shandong Ruifeng Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Innovative Medical

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Shandong Ruifeng and Innovative Medical

The main advantage of trading using opposite Shandong Ruifeng and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shandong Ruifeng position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.

The idea behind Shandong Ruifeng Chemical and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.